Vivos Therapeutics Inc. (VVOS)
undefined
undefined%
At close: undefined
4.76
2.59%
After-hours Dec 13, 2024, 07:58 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 13.80M 16.02M 16.89M 13.07M 11.39M 3.79M
Cost of Revenue 5.53M 6.00M 4.28M 2.65M 2.74M 1.08M
Gross Profit 8.27M 10.02M 12.60M 10.41M 8.66M 2.71M
Operating Income -17.30M -25.03M -19.47M -8.71M -10.58M -8.34M
Interest Income - 89.00K 117.00K 79.61K 21.13K -
Pretax Income -13.58M -23.84M -20.29M -12.06M -10.75M -8.44M
Net Income -13.58M -22.66M -20.29M -8.82M -10.89M -8.54M
Selling & General & Admin 24.85M 34.38M 31.34M 18.40M 18.48M 10.44M
Research & Development 100.00K 200.00K - - - -
Other Expenses 621.00K 669.00K 733.00K 717.87K 751.23K 610.67K
Operating Expenses 24.95M 35.05M 32.08M 19.12M 19.23M 11.05M
Interest Expense - - 14.00K 96.68K 137.88K 102.97K
Selling & Marketing Expenses 2.47M 5.34M 5.55M 2.31M 2.31M 1.16M
Cost & Expenses 31.10M 41.05M 36.36M 21.78M 21.97M 12.13M
Income Tax - -1.19M 5.00K -3.23M 137.88K 102.97K
Shares Outstanding (Basic) 1.22M 920.48K 849.32K 728.38K 496.43K 461.93K
Shares Outstanding (Diluted) 1.22M 920.48K 849.32K 728.38K 496.43K 461.93K
EPS (Basic) -11.14 -24.62 -23.89 -12.11 -21.94 -18.49
EPS (Diluted) -11.14 -24.62 -23.89 -12.11 -21.94 -18.49
EBITDA -16.68M -24.36M -19.54M -11.24M -9.87M -7.73M
Depreciation & Amortization 621.00K 669.00K 733.00K 717.87K 751.23K 610.67K